Circulating epinephrine and norepinephrine are avidly absorbed and stored by the heart muscle but not by skeletal muscle of dogs. Stimulation of the cardiac sympathetic nerves augments myocardial norepinephrine but not epinephrine. Sympatholytic drugs do not diminish, some even increase active catecholamines in heart muscle. The results explain a number of pathophysiologic conditions briefly enumerated.
T HE important role, played by the oxygen-wasting, potentially hypoxiating sympathomimetic catecholamines, epinephrine and norepinephrine, in various myocardial disorders 1 suggested the following study of their concentration in the heart muscle of the dog. Normal and certain experimental conditions were investigated and the concentrations of these substances in cardiac and skeletal muscle were compared. METHODS Dogs, anesthetized with Nembutal, were killed by quickly excising the heart. Pericardium, fat and large vessels were removed, the chambers were cut open and the surfaces were dried with filter paper. The coronary vascular system was not flushed, in order to avoid falsification of the results by washing out catecholamines from the tisaue. Besides, the catechol content of the coronary blood, even after injection of large doses of epinephrine and norepinephrine, proved too small to constitute a significant source of error. Muscles of the thigh were dissected and, likewise, dried on the surface with filter paper.
The tissues were extracted and prepared for (1) colorimetric assay of total catechols with the method of Shaw, as modified by one of us, 5 and (2) bioassay of norepinephrine and epinephrine separately, according to von Euler's method, as described in detail by Goodall' and ourselves 4 ; the blood pressure of Nembutal-anesthetized, atropinized and coFrom the Division of Experimental Medicine, University of Vermont, College of Medicine, Burlington, Vt.
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cainized cats with the adrenals tied off and the hen's isolated rectal coecum were used. The stellate ganglia and/or postganglionic sympathetic fibers of the heart were stimulated unilaterally or bilaterally for 5 to 36 (average 20) minutes, and the crural nerves unilaterally (10 minutes), with attached shielded electrodes, using AC current from a "variable voltage-constant output" transformer (Variac). The lowest voltages which produced definite cardiac acceleration or vigorous muscular contractions respectively were applied. They varied between 2 and 25 volts. Stimulation of the crural nerves was done rhythmically to elicit 120 conti-actions per minute.
Norepinephrine (10 mg. per Kg.) and epinephrine (10 mg. per Kg.) or both combined (3.S mg. per Kg. epinephrine plus 7.5 mg. per Kg. norepinephrine) were injected intraperitoneally. Except in a few cases of spontaneous death from epinephrine toxieity, the clogs were killed 10 minutes after injection.
Regitine (3 mg. per Kg.) and benzodioxane (5 mg. per Kg.) were injected intraperitoneally, Dibenamine (20-30 mg. per Kg.) was given intravenously. The dogs were killed 15 to 30, 45 to 70 and 60 to 120 minutes respectively after injections. In one group, bilateral stimulation of the cardiac sympathetic nerves was carried out for 15 minutes, beginning 10 minutes after intravenous injection of Regitine (3 mg. per Kg.). Stimulation of the crural nerves was begun at the time of intraperitoneal injection of norepinephrine and epinephrine and continued for 10 minutes until the dogs were killed, except in cases of earlier death from epinephrine toxicity. In some of the experiments, the heart rate was registered electrocardiographically by Dr. E. Lepeschkin.
RESULTS
In the control hearts, norepinephrine constituted, on an average, 84 per cent of the pharmacodynamically active catecholamines, the rest being epinephrine. The colorimetric readings for total catecholamines, expressed in color units (each unit equalling the color intensity of 0.001 Mg-of epinephrine) were several times higher than bioassay-recovered norepinephrine and epinephrine combined (table 1) . This is probably due to the participation of some other pharmacodynamically inactive chromogenic catechols in colorimetry, and to partial inactivation of norepinephrine and epinephrine during the extraction process for bioassay, while the chromogenic and adsorbable catechol ring remains intact at pH 8.5.
Electric stimulation of the cardiac sympathetic nerves augmented the myocardial norepinephrine content (+93 per cent) but left the epinephrine concentration practically unchanged. Injection of norepinephrine was followed by a marked increase of the myocardial norepinephrine alone. Injection of epinephrine resulted in an enormous accumulation of epinephrine in the heart. Norepinephrine was also increased. Combined injection, norepinephrine and epinephrine in a 1:2 proportion, led to the greatest accumulation of both in approximate proportion.
The injections of norepinephrine and epinephrine produced also large proportionate increases of the colorimetrically demonstrable total myocardial catechols. In these instances, the colorimetric values corresponded rather closely to the bioassay results, indicating that practically the entire mass of catecholamines absorbed by the myocardium was recovered in an active form. and epinephrine in the heart muscle, but Dibenamine and Regitine produced even an augmentation of myocardial norepinephrine. After administration of Regitine, combined electric stimulation of the cardiac sympa-thetic nerves, the norepinephrine augmentation was not greater than that produced by either one of these two procedures per se (tables 1, 2). The discrepancies between coJorimetric and bioassay values were smaller in the animals treated with sympatholytic drugs than in the controls. In order to evaluate a possible error, caused by the amounts of catecholamines, present in the coronary blood of the non-flushed hearts at the time of the animals' death, 2 hearts of epinephrine-injected dogs and 2 hearts of norepinephrine-injected dogs were thoroughly flushed through the coronary bed with 1200 cc. of Ringer solution before extraction, and besides, 40 cc. arterial blood samples were withdrawn before injection and again 10 minutes after injection, immediately before the animals were sacrificed.
In table 3, a comparison between the average results, obtained from the nonflushed and flushed hearts, shows an apparently considerable loss of excess myocardial epinephrine, due to washing out of the heart muscle, yejt abnormally large excess quantities remained, while all the absorbed norepinephrine seemed to be firmly anchored on the myocardial cells and non-removable by washing. The maximal amount of coronary blood, present in the heart muscle after epinephrine injection, was 7 per cent of the myocardial volume (W. van B. Robertson, personal communication). On this basis, 7 per cent of the catechols contained in 1 cc. of blood have to be correlated with the catechol content of 1 gram of heart muscle tissue in order to evaluate the degree to which blood catechols interfered in the myoeardial readings. (table 1) shows that the norepinephrine plus epinephrine of the coronary blood constitutes only 0.4 to 3 per cent of the norepinephrine plus epinephrine values, obtained from the non-flushed myocardium. The corresponding percentages for the chromogenic total catechol readings range from 0.6 to 2 per cent. Thus, the coronary blood catechols are not a significant source of error and can be safely disregarded.
Both norepinephrine and total catechols were present in smaller amounts in the striated muscles of the thigh than in the heart (table 5). Epinephrine constituted a larger average fraction. Neither rhythmic electric stimulation of the supplying somatic nerves nor injection of norepinephrine and epinephrine nor a combination of these injections with rhythmic stimulation produced a major change of the active catecholamines, even though there seemed to be a slight tendency of injected epinephrine to accumulate in the muscles. The amounts of inactive chromogenic catecholamines were significantly augmented after all injections, suggesting a rapid enzymatic inactivation of the injected catecholamines, however with preservation of their adsorbable chromogenic catechol nucleus.
DISCUSSION
Our results confirm other observations 3 ' 6i 6> 7
and our own 4 in various animal species and in human hearts: norcpinephrine forms the bulk of the pharmacodynamically active eatecholamines in the normal mammalian heart. Beside norepinephrine and epinephrine, the heart muscle contains considerable quantities of chromogenic catechols with negligible pharmacodynamic activity (e.g., hydroxytyramine
). This is also manifested by the large discrepancy between our colorimetric and bioassay readings. Cardiac sympathetic stimulation liberates norepinephrine at the postganglionic nerve terminals and thus accelerates the heart rate and increases myocardial oxygen consumption. 8 ' 9 In striking contrast to the skeletal muscle, the myocardium displays an amazing avidity to absorb and store in an active form large quantities of injected norepinephrine and, even more so, of epinephrine. This appeared at a maximum when both were combined. The simultaneous augmentation of myocardial norepinephrine which was observed after the injection of epinephrine, could possibly be attributed to agonal discharges of norepinephrine from the postganglionic sympathetic nerve endings into the myocardium. However, in view of the inhibitory action of epinephrine on the sympathetic ganglionic synapses, 10 this explanation appears unlikely. An enzymatic demethylation of excess epinephrine within the heart muscle is another possibility. That the large accumulations of epinephrine in the myocardium did not prove fatal in all instances, may be ascribed to the fact that epinephrine toxieity on the heart has an upper limit" lieyond which no further augmentation of toxic action on the myocardial cell surfaces seems to be possible.
The relatively good agreement between the colorimetric and the bioassay values after injection of norepinephrine and epinephrine suggests that norepinephrine and epinephrine are not materially inactivated during the extraction for bioassay.
The failure of some of the most potent sympatholytic drugs (benzodioxane, Dibenamine, Regitine) to diminish the quantity and pharmacodynamic effectiveness of the extractable active cardiac catecholamin.es, both under standard conditions and during sympathetic nerve stimulation, parallels the comparative ineffectiveness of these drugs as adrenergic blocking agents on the heart. 12 ' "• H It also suggests that the catecholamin.es exert a competitive rather than a destructive or membrane permeability-altering action. The augmentation of cardiac norepinephrine by Dibenamine and Regitine may serve as an explanation of the cardiac acceleration which is often elicited by these drugs;"' 14 -' 6 intramyocardially liberated norepinephrine produces a positive chronotropic effect, in contrast to parenterally administered, circulating norepinephrine which sets overwhelming inhibitory vagal counterreflexes into motion via the peripheral vascular pressoreceptors. The somewhat diminished discrepancy between colorimetric and bioassay readings after administration of the sympatholytic drugs suggests that they promote an activation or re-activation of some of the preformed inactive cardiac catechols.
The low norepinephrine and total catechol contents of the striated muscle, the failure of its active cateeholamine concentration to rise after cateeholamine injections or nerve stimulation and the apparent ability of the skeletal muscle to rapidly inactivate absorbed injected catecholamincs, set the skeletal muscle distinctly apart from heart muscle as far as cateeholamine action and metabolism are concerned. These differences are believed to account for the comparatively minimal dynamic response of the skeletal muscle to injected or secreted catecholamines, and also to account for the absence of catecholamineinduced degenerative changes in the skeletal musculature, as contrasted with those which are so frequently encountered in the catecholrich myocardium.
A variety of pathophysiologie observations concerning the potentially hypoxiating activity of myocardial catecholamines can be interpreted on the basis of the above findings. AVe are specifically referring to (1) the acute, painful myocardial hypoxia under conditions associated with adreno-sympathogenic stimulation (angina pectoris) 18 ; (2) the cardiotoxic accumulation of myocardial catecholamines in severe renal insufficiency 1 ' •• 17 which is due to abnormally high catechol levels in the blood; (3) the "high cardiac output" congestive failure of the abnormally catecholamine-rich.
beri-beri heart 8 -"; (4) the therapeutically beneficial diminution of the myocardial catecholamines following sympathectomy*' 19 and (5) the relative therapeutic inefficacy of sympatholytic medication in such cardiac disorders as the tachycardias and angina pectoris.
1 ' "• u
SUMMARY
Heart muscle of the dog (like that of other mammalian species) contains norepinephrine and epinephrine in the approximate proportion of 5:1 and relatively large quantities of pharmacodynamically inactive catechol compounds.
Stimulation of the cardiac sympathetic nerves augments myocardial norepinephrine without altering the epinephrine concentration.
Injected, circulating norepinephrine, and even more so, epinephrine, are eagerly absorbed by the heart muscle and stored in an active form in large quantities.
Sympatholytic drags (benzodioxane, Dibenamine, Regitine) do not diminish the amounts and pharmacodynamic effectiveness of myocardial norepinephrine and epinephrine. Dibenamine and Regitine even cause an increase of myocardial norepinephrine.
Skeletal muscle differs strikingly from heart muscle: I t contains less norepinephrine and total catechols. Its catecholamine concentration remains practically unchanged by somatic nerve stimulation, by injections of norepinephrine or epinephrine and by combinations of these. I t seems to inactivate its excess catecholamine deposits rapidly.
The significance of some of the enumerated findings in understanding the role of adrenosympathogenic catecholamines in the origin of certain clinical cardiac disorders is briefly mentioned.
